Next, we constructed a second-generation anti-CD19-41BBz CAR under the control of the 2xAARE-YB promoter in T cells to investigate its regulation under AA-limited conditions in different tumor models harboring the same target antigen (Fig. 3D). The gene discussed is CD19; the disease is neoplasm.